New York, February 23, 2018: The global genome Editing market is expected to grow at a CAGR of more than 14.0% between 2015 and 2023. The global genome Editing market is estimated to cross US$ 7.0 billion by the end of 2023.
Recent developments across genome editing technologies have resulted in the creation of next generation nucleases that have higher levels of accuracy when correcting genetic mutations and defects. The classes under the genome editing technologies are the 4 broad families of nucleases: ZFNs, TALENs, CRISPR/Cas9, and Meganucleases.
Gene editing technologies have an impact across multiple applications areas including plant and animal genetic engineering. However, the area of most disruption is across human cell line engineering, which enables the development of next generation’s therapies and drugs. However, the agricultural industry has seen more success with gene editing techniques largely due to the less stringent regulatory environment.
This market research report categorizes the genome editing market into the following segments:
• Antisense Technology
• Other Technologies
Cell Line Engineering
• Animal Genetic Engineering
• Plant Genetic Engineering
• Other Applications
By End User
- Biotechnology and Pharmaceutical Companies
• Government and Academic Research Institutes
• Other Research Organizations
By Geographical Region
- North America
• Rest of the World
The global genome editing market is rapidly increasing due to the increased government funding for genomics technology, rise in the production of genetically modified crops and technological advancements these all factors are driving the growth of this market.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States